[Click here to subscribe to our NEW weekly newsletter!!]

Saved Google Search 02/09/2003 . . . courtesy of

[Note that many of these links expire after a few weeks]

Go to Google News Home
News BETA
Preferences    Search Tips 
 
 Web 
 Images 
 Groups 
 Directory 
 News 
Searched news for Strattera. (BETA)  Results 1 - 51 of 51. Search took 0.36 seconds.
   Top Stories
   World
   U.S.
   Business
   Sci/Tech
   Sports
   Entertainment
   Health

About Google News

Sort by relevance   Sorted by date

Did you mean: Strata  

Attention deficit disorder for adults
LA Times, CA - 11 hours ago
... The Indianapolis drug maker has been heavily marketing the drug Strattera,
also known as atomoxetine, for attention deficit/hyperactivity disorder. ...

The Facts on Strattera
Washington Post, DC - 04 Feb 2003
Strattera is taken once a day; dose amounts are determined by
the patient's body weight. Washington psychiatrist Nora Galil ...

A New Choice for Treating ADHD
Washington Post, DC - 03 Feb 2003
... But if research and clinical trials prove correct, the newly released drug Strattera,
the object of the callers' questions, will help many children with ...

THE RATINGS GAME
CBS MarketWatch (subscription) - 03 Feb 2003
... steady progress with its manufacturing issues, that key pipeline drugs appear likely
to launch within the ensuing months, and that newly launched Strattera is ...

Indiana is 12th in study of ADHD
Indianapolis Star, IN - 03 Feb 2003
... and Concerta. Strattera, an ADHD drug made by Eli Lilly and Co., hit
the market this month and was not included in the survey. The ...

Lilly's And Schering's Blockbuster Hangovers
Forbes - 24 Jan 2003
... Strattera, a nonstimulant treatment for attention deficit disorder, and osteoporosis
drug Forteo have both been approved by the FDA and launched in the past ...

Strong quarter caps '02 for Lilly
Indianapolis Star, IN - 23 Jan 2003
... Two drugs hit the US market in the past few weeks: Strattera for attention-deficit
hyperactivity disorder and Forteo for osteoporosis. ...

Lilly Posts Profit, but Issues Warning
ABC News - 23 Jan 2003
... It won approval in November for two long-delayed medicines, Strattera
for attention deficit disorder and Forteo for osteoporosis. ...

Lilly Posts Profit, but Issues Warning
Reuters, UK - 23 Jan 2003
... It won approval in November for two long-delayed medicines, Strattera
for attention deficit disorder and Forteo for osteoporosis. ...

Lilly Posts 28 Percent Earnings Increase
Austin American Statesman, TX - 23 Jan 2003
... president and chief executive, said the drug maker has turned the corner with the
November approval of two drugs: Forteo, to treat osteoporosis, and Strattera ...

Lilly Posts 28 Percent Earnings Increase
ABC News - 23 Jan 2003
... president and chief executive, said the drug maker has turned the corner with the
November approval of two drugs: Forteo, to treat osteoporosis, and Strattera ...

Lilly Posts 28 Percent Earnings Increase
Kansas City Star, MO - 23 Jan 2003
... president and chief executive, said the drug maker has turned the corner with the
November approval of two drugs: Forteo, to treat osteoporosis, and Strattera ...

Lilly Earnings Rise, but Shares Fall
ABC News - 23 Jan 2003
... president and chief executive, said the drug maker has turned the corner with the
November approval of two drugs: Forteo, to treat osteoporosis, and Strattera ...

3 Drugmakers Post Gains, 2003 Seen Hard
ABC News - 23 Jan 2003
... He said Lilly should emerge strong after 2003 because of the recent approval of
its drug Strattera for attention deficit disorder and expected approval this ...

Lilly's And Schering's Blockbuster Hangovers
Forbes - 23 Jan 2003
... Strattera, a nonstimulant treatment for attention deficit disorder, and osteoporosis
drug Forteo have both been approved by the FDA and launched in the past ...

Lilly's And Schering's Blockbuster Hangovers
Forbes - 23 Jan 2003
... Strattera, a nonstimulant treatment for attention deficit disorder, and osteoporosis
drug Forteo have both been approved by the FDA and launched in the past ...

3 Drugmakers Post Gains, 2003 Seen Hard
Reuters, UK - 23 Jan 2003
... He said Lilly should emerge strong after 2003 because of the recent approval of
its drug Strattera for attention deficit disorder and expected approval this ...

Lilly Posts 28 Percent Earnings Increase
Austin American Statesman, TX - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Springfield News Sun, OH - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Seattle Times, WA - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
ABC News - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
ABC News - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
San Jose Mercury News, CA - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Miami Herald, FL - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
ABC News - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Sarasota Herald-Tribune, FL - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Lakeland Ledger, FL - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Springfield News Sun, OH - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Seattle Post Intelligencer, WA - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly's Fourth Quarter Marks a Return to Quarterly Sales Growth ...
BusinessWire (press release) - 23 Jan 2003
... Strattera(TM) was approved by the US Food and Drug Administration (FDA) for the
treatment of attention-deficit hyperactivity disorder (ADHD) in children ...

5 For Kids: New ADHD Drug
WLWT, OH - 20 Jan 2003
... But now, there is a new drug on the market known as Strattera. It's the first FDA
approved non-stimulant that manufacturers say will offer fewer side-effects. ...

Drugmakers Rx: can't get much worse
CNN Europe, Europe - 20 Jan 2003
... As for Eli Lilly, in November it won federal marketing approval for
Strattera, to treat attention deficit hyperactivity disorder. ...

Drugmakers Rx: can't get much worse
CNN/Money - 20 Jan 2003
... As for Eli Lilly, in November it won federal marketing approval for
Strattera, to treat attention deficit hyperactivity disorder. ...

Eli Lilly: Straterra likely to narrow revenue deficit
UK Comment Wire, UK - 17 Jan 2003
January 17, 2003 12:50 PM GMT (Datamonitor) - Eli Lilly's Strattera
is set to add a new dimension to the US ADHD market. It is the ...

Lilly's ADHD drug hits the market
Indianapolis Star, IN - 15 Jan 2003
... Strattera is expected to be a major seller for the Indianapolis drugmaker as a
treatment for attention-deficit/hyperactivity disorder in both children and ...

Daily briefing
The News Journal, DE - 15 Jan 2003
... Eli Lilly and Co., which won federal marketing approval for Strattera
in November, said more than 46000 pharmacies have stocked the drug.

New Lilly drug expects promising sales
WTHR, IN - 14 Jan 2003
Cathie's son took part in a clinical trial on the Eli Lilly and Company
drug Strattera. It hit pharmacy shelves Tuesday. Strattera ...

Lilly's Attention Deficit Drug Available
WMAR (ABC2), MD - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

New attention deficit drug hits US pharmacies
CTV, Canada - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's new attention deficit drug Strattera hits US pharmacies
Ottawa Citizen, Canada - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's new attention deficit drug Strattera hits US pharmacies
St. Catharines Standard, Canada - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's new attention deficit drug Strattera hits US pharmacies
Canada.com, Canada - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

New Lilly drug arrives in pharmacies
Indianapolis Star, IN - 14 Jan 2003
... Strattera is expected to be a major seller for the Indianapolis drugmaker as a
treatment for attention-deficit/hyperactivity disorder in both children and ...

Lilly's Attention Deficit Drug Available
Sarasota Herald-Tribune, FL - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's Attention Deficit Drug Available
ABC News - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's Attention Deficit Drug Available
Lakeland Ledger, FL - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's Attention Deficit Drug Available
Times Daily, AL - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's Attention Deficit Drug Available
Newsday - 14 Jan 2003
... Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's New ADHD Drug Now Available in Pharmacies
WISH, IN - 14 Jan 2003
... in pharmacies. The drug is called Strattera and is the first non-stimulant
drug approved by the FDA for treating ADHD. Lilly says ...

Lilly's new attention deficit drug hits pharmacies
Miami Herald, FL - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Drugs: Relief from the Pain
BusinessWeek - 06 Jan 2003
... Eli Lilly & Co. (LLY ) is also likely to launch Strattera, for attention-deficit
hyperactivity disorder, and a new antidepressant called Cymbalta. ...

Did you mean to search for: Strata  



Google Home - Advertise with Us - Search Solutions - Services & Tools - Jobs, Press, & Help

©2003 Google